Showing results (1091-1100 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 20, 2020
Identification of Inhibitors of Thrombospondin 1 Activation of TGF-βMark J Suto, Vandana Gupta, Bini Mathew, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-PyrimidinesMami Sato, Hirokazu Fuchida, Naoya Shindo, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion ProteinsToru Yamaguchi-Sasaki, Seiken Tokura, Yuya Ogata, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Polysaccharide-Based Nanoparticles for Two-Step Responsive Release of Antitumor DrugHong-Guang Fu, Yong Chen, Qilin Yu, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Novel HIV-1 Protease Inhibitors with Morpholine as the P2 Ligand to Enhance Activity against DRV-Resistant VariantsMei Zhu, Yue Dou, Ling Ma, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 HydrolaseLena Hefke, Kerstin Hiesinger, W Felix Zhu, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer InterfaceMingxing Teng, Scott B Ficarro, Hojong Yoon, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
P2Y14 Receptor Antagonists Reverse Chronic Neuropathic Pain in a Mouse ModelFatma Mufti, Young-Hwan Jung, Luigino Antonio Giancotti, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Discovery of a Potent Anticancer Agent PVHD303 with in Vivo ActivityYumiko Suzuki, Ayana Otake, Satoshi Ueno, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Discovery of 2,6-Dimethylpiperazines as Allosteric Inhibitors of CPS1Alan Rolfe, Shihua Yao, Toung-Vi Nguyen, et al.
Pageof 438